Geneos Wealth Management’s Aehr Test Systems AEHR Stock Holding History

Geneos Wealth Management’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,000	Closed	-$12.4K	–	2056
2024 Q1	$12.4K	Hold	1,000	–	–	﹤0.01%	1498
2023 Q4	$26.5K	Hold	1,000	–	–	﹤0.01%	1266
2023 Q3	$45.7K	Hold	1,000	–	–	﹤0.01%	1106
2023 Q2	$41.3K	Hold	1,000	–	–	﹤0.01%	1133
2023 Q1	$31K	Hold	1,000	–	–	﹤0.01%	1213
2022 Q4	$20.1K	Hold	1,000	–	–	﹤0.01%	1338
2022 Q3	$14K	Hold	1,000	–	–	﹤0.01%	1424
2022 Q2	$6K	Hold	1,000	–	–	﹤0.01%	2112
2022 Q1	$10K	Buy	+1,000	New	+$12.8K	﹤0.01%	2079

Other funds holding AEHR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

HFF

Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geneos Wealth Management's AEHR Position: Q2 2024 in Review

Geneos Wealth Management sold out of Aehr Test Systems (AEHR) in Q2 2024, closing a stake of 1,000 shares — an estimated $12.4K sold.

Geneos Wealth Management first reported a position in AEHR in Q1 2022 and held it in 9 quarters. The position peaked at $45.7K in Q3 2023. 119 funds tracked by Wall St. Rank hold AEHR as of Q2 2024.

Geneos Wealth Management reported no remaining Aehr Test Systems position as of Q2 2024 after selling out during the quarter.
Geneos Wealth Management sold 1,000 Aehr Test Systems shares in Q2 2024, an estimated $12.4K.
Geneos Wealth Management first reported a position in Aehr Test Systems in Q1 2022 and held it in 9 quarters.
Geneos Wealth Management's Aehr Test Systems position peaked at $45.7K in Q3 2023.
119 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2024.

Based on Geneos Wealth Management's 13F filing for Q2 2024, filed 23 Jul 2024.